Browsing: healthcare

Healthcare need not come with a dose of financial ruin; 50,000 Hawaiʻi residents may qualify for relief : Maui Now Maui News

Ky. (WKYT) – Hundreds of families turned out Saturday for UK HealthCare’s Back to School Extravaganza at Consolidated Baptist Church, where more than a dozen organizations partnered to provide free health and educational re

As healthcare affordability continues to persist as a top concern for voters ahead of the 2026 midterm elections, the Trump administration has pursued Medicare and Medicaid fraud across the country. In February, President Donald Trump announced the White House Fraud Task Force, a group led by Vice President JD Vance to pursue fraud schemes across…

VIENTIANE (Xinhua): Laos will continue upgrading central and provincial hospitals while strengthening primary healthcare services in rural areas to ensure equitable access to quality medical care nationwide

When H.R. 1, also known as the One Big Beautiful Bill Act, passed last year on the Fourth of July, we knew that helping people stay enrolled in the Medicaid program — known as Medi-Cal in California — would be a challenge unlike any other we had faced in the 15-year history of Gold Coast…

Healthcare leaders in New York are warning of a potential caregiver crisis if Temporary Protected Status is permanently revoked from immigrant healthcare workers

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 11.5% over the past six months, topping the S&P 500 by 4.3 percentage points

Leonard Abramson, 93, of Jupiter, Fla., a former pharmacist, founder, chair, and chief executive officer of U.S. Healthcare Inc., author, trustee emeritus at Johns Hopkins University, and one of the world’s most generous cancer research and clinical care philanthropists, died Saturday, July 4, of age-associated decline at his home in Blue Bell, Montgomery County

Investors seeking exposure to healthcare innovation often have to choose between the stability of established pharmaceutical giants and the higher-growth, higher-risk profile of clinical-stage biotech firms. This comparison looks at the two popular funds — the iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) and the iShares Biotechnology ETF (NASDAQ:IBB)– to see how their differing concentration, volatility, and…

Like many people who are or have been homeless, Jessica Scott struggles with debilitating anxiety